There Is Still Room For Augmedix Inc. (AUGX) to Improve Its Value – Let’s Wait for Clarity

The closing price of Augmedix Inc. (NASDAQ: AUGX) was $1.65 for the day, down -0.60% from the previous closing price of $1.66. In other words, the price has decreased by -$0.0099 from its previous closing price. On the day, 1593810 shares were traded. AUGX stock price reached its highest trading level at $1.7300 during the session, while it also had its lowest trading level at $1.4900.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.



Our analysis of AUGX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.10 and its Current Ratio is at 2.10. In the meantime, Its Debt-to-Equity ratio is 2.32 whereas as Long-Term Debt/Eq ratio is at 2.03.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 13 when Ginocchio Paul bought 18,000 shares for $1.20 per share. The transaction valued at 21,600 led to the insider holds 118,000 shares of the business.

McKesson Ventures, LLC sold 2,410,000 shares of AUGX for $2,530,500 on Dec 13. The Former 10% Owner now owns 1,572,432 shares after completing the transaction at $1.05 per share. On Oct 05, another insider, McKesson Ventures, LLC, who serves as the 10% Owner of the company, sold 3,307 shares for $1.30 each. As a result, the insider received 4,299 and left with 3,982,432 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 2.16 while its Price-to-Book (P/B) ratio in mrq is 9.71.

Stock Price History:

Over the past 52 weeks, AUGX has reached a high of $3.37, while it has fallen to a 52-week low of $1.01. The 50-Day Moving Average of the stock is 1.3443, while the 200-Day Moving Average is calculated to be 1.7454.

Shares Statistics:

AUGX traded an average of 78.60K shares per day over the past three months and 185.6k shares per day over the past ten days. A total of 37.43M shares are outstanding, with a floating share count of 30.92M. Insiders hold about 10.60% of the company’s shares, while institutions hold 62.30% stake in the company. Shares short for AUGX as of Oct 13, 2022 were 97.18k with a Short Ratio of 0.03M, compared to 98.96k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.26% and a Short% of Float of 0.67%.

Earnings Estimates

The firm’s stock currently is rated by 3 analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.18, while EPS last year was -$0.19. The consensus estimate for the next quarter is -$0.17, with high estimates of -$0.15 and low estimates of -$0.19.

Analysts are recommending an EPS of between -$0.63 and -$0.73 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is -$0.63, with 3 analysts recommending between -$0.5 and -$0.71.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $7.8M to a low estimate of $7.68M. As of the current estimate, Augmedix Inc.’s year-ago sales were $5.62M, an estimated increase of 37.80% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $8.37M, an increase of 27.30% less than the figure of $37.80% in the same quarter last year. There is a high estimate of $8.58M for the next quarter, whereas the lowest estimate is $8.12M.

A total of 5 analysts have provided revenue estimates for AUGX’s current fiscal year. The highest revenue estimate was $30.63M, while the lowest revenue estimate was $30.2M, resulting in an average revenue estimate of $30.43M. In the same quarter a year ago, actual revenue was $22.16M, up 37.30% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $39.83M in the next fiscal year. The high estimate is $40.43M and the low estimate is $38.6M. The average revenue growth estimate for next year is up 30.90% from the average revenue estimate for this year.